Skip to content

Effect of HIV-1 DNA Repository on Immune Reconstruction of AIDS Patients

Effect of HIV-1 DNA Repository on Immune Reconstruction of AIDS Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027695
Enrollment
Unknown
Registered
2019-11-23
Start date
2019-11-25
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS

Interventions

Experimental group:Chinese medicine intervention treatment
Control group:Placebo

Sponsors

Henan Infectious Disease Hospital (Zhengzhou Sixth People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years old; 2. Male or female; 3. ART treatment > 24 months; 4. The number of CD4 cells 350/ul each 100 cases; 5. HIV-1 RNA viral load is lower than the detection level (<40 copies/ml).

Exclusion criteria

Exclusion criteria: 1. Antiviral therapy is less than 2 years; 2. Combine all types of opportunistic infections; 3. Pregnant women or women of childbearing age who have a pregnancy plan; 4. Patients with tumors; 5. Poor medication compliance; 6. Patients with mental illness or previous history of mental illness; 7. Suspect or determine the history of alcohol and drug abuse; 8. Those who have entered other clinical trials in the past 3 months; 9. Other factors that the investigator believes are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
HIV-1DNA;CD4;

Secondary

MeasureTime frame
CD4/CD8;

Countries

China

Contacts

Public ContactChen Zhaoyun

Zhengzhou Sixth People's Hospital

chenzhaoyun@126.com+86 13703936321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026